Viewing Study NCT00616005


Ignite Creation Date: 2025-12-25 @ 3:11 AM
Ignite Modification Date: 2026-02-27 @ 8:28 AM
Study NCT ID: NCT00616005
Status: COMPLETED
Last Update Posted: 2014-08-18
First Post: 2008-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
Sponsor: Duke University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module